| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |